1. Home
  2. RNA vs REA Comparison

RNA vs REA Comparison

Compare RNA & REA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

SELL

Current Price

$6.45

Market Cap

141.3M

Sector

Health Care

ML Signal

SELL

Logo Rare Earths Americas Inc. Common Stock

REA

Rare Earths Americas Inc. Common Stock

HOLD

Current Price

$4.56

Market Cap

117.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNA
REA
Founded
2025
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
141.3M
117.8M
IPO Year
2025
2026

Fundamental Metrics

Financial Performance
Metric
RNA
REA
Price
$6.45
$4.56
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$22.00
★ $24.53
AVG Volume (30 Days)
★ 205.6K
157.4K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$104.53
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.47
$5.26
52 Week High
$73.06
$17.84

Technical Indicators

Market Signals
Indicator
RNA
REA
Relative Strength Index (RSI) 24.72 28.69
Support Level N/A N/A
Resistance Level $8.50 $9.04
Average True Range (ATR) 0.42 0.83
MACD -0.09 -0.19
Stochastic Oscillator 1.49 1.10

Price Performance

Historical Comparison
RNA
REA

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

About REA Rare Earths Americas Inc. Common Stock

Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goias, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.

Share on Social Networks: